Holiday season could strain COVID-19 home test supplies as more Americans try to screen themselves before Thanksgiving and other family gatherings.
ABC News Chief Medical Correspondent Dr. Jen offers her advice on how to best protect yourself and others against COVID-19 while traveling this holiday season.WASHINGTON -- Millions more home tests for COVID-19 are hitting store shelves, but will there be enough for Americans hoping to screen themselves before holiday gatherings?
She began testing herself regularly in September after flights to Las Vegas and the East Coast for vacation. Because local pharmacies sometimes sell out of tests, she usually buys five packs at a time when she finds them. “I couldn't find them for the longest time," said Denise Weiss, a retired musician in suburban Philadelphia.
Large employers and private universities are also buying up millions of tests. Under the Biden administration’s vaccine mandate for large employers, workers who haven’t been vaccinated are supposed to get tested weekly starting in January.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Protesters petition Robin Swann over care home Covid rulesResidents' relatives said pandemic restrictions are having a detrimental affect on their loved ones.
Read more »
New hurdle for COVID-19 home testing -- the holiday seasonWASHINGTON (AP) — Millions more home tests for COVID-19 are hitting store shelves, but will there be enough for Americans hoping to screen themselves before holiday gatherings? Gone are last year's long lines to get tested, thanks to nearly a year of vaccinations, increased testing supplies and quicker options.
Read more »
U.S. looking to broaden access to COVID-19 antiviral pills - WSJThe administration is reviewing whether Paxlovid, the antiviral from Pfizer Inc, can be available on the commercial market in retail pharmacies if it gets regulatory clearance, the Journal reported. Molnupiravir, an oral pill from Merck & Co Inc and Ridgeback Biotherapeutics LP that is also under regulatory review, may be included in the government's plan to make it commercially available, the journal reported, citing the person. The United States has agreed to buy 10 million courses of Pfizer's drug and has so far secured 3.1 million courses of Merck's pill.
Read more »
Canada's cannabis companies cut 6,000 jobs during COVID-19 pandemicCanopy Growth, Tilray, Sundial and Aurora Cannabis led job losses during the COVID-19 pandemic as the Canadian cannabis sector overbuilt production capacity,...
Read more »
FDA authorizes Pfizer/BioNTech, Moderna COVID-19 boostersThe U.S. Food and Drug Administration on Friday authorized booster doses of COVID-19 vaccines for all adults who were vaccinated with the Pfizer Inc and partner BioNTech SE shot and the Moderna Inc shot.
Read more »